Advertisement

Topics

Advanced Proteome Therapeutics Announces 2017 AGM Results and Corporate Update

20:00 EDT 30 Jul 2017 | Marketwired

VANCOUVER, BC--(Marketwired - July 31, 2017) - Advanced Proteome Therapeutics Corporation
("APC
" or the "Company
") (TSX VENTURE: APC) (FRANKFURT: 0E8) a biotechnology company focused on developing superior targeted protein therapeutics, today announced the election of its board of directors from its Annual General Meeting (the "AGM
") of shareholders, held on Wednesday July 26, 2017.

Shareholders elected Dr. Randal D. Chase (President and CEO of the Company), Dr. Alexander (Allen) Krantz (CSO, COO and Secretary of the Company), Thom Skinner and Paul Kirkconnell as directors of the Company.

Additionally, the shareholders of the Company passed the following resolutions:

Operational Update

The Company's management is pleased to provide its shareholders an overview of the progress of the Company during FY 2017.

The Company continues to drive towards the development of their own product suite as well as showing viability of their novel linker technology for licensing purposes. In FY 2017 major strategic and operational changes have taken place to set the stage for a future of rapid growth.

Milestones achieved during FY 2017 include:

"We are very pleased to state that we have gathered substantial momentum in our programs during 2017 and we have been able to make key structural and operational changes within the organization," stated Dr. Randal Chase, President and CEO of the Company. "We are now in a position to successfully execute on our growth strategy of partnering our proprietary linker technology with leading institutions around the world, and developing our product suite."

ABOUT THE COMPANY:

Advanced Proteome Therapeutics Corporation is developing a proprietary technology to directly target cancerous tumors and avoid destroying normal cells. This type of agent is capable of greater potency, higher specificity, and lower toxicity than other therapies that can also attack healthy cells. Advanced Proteome is working to streamline the process by which these agents are prepared, which to date, has been extremely cumbersome, limiting their potential.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This communication contains certain forward-looking statements relating to the Company's business, which can be identified by the use of forward-looking terminology such as "estimates", "believes", "expects", "may", "will", "should", "future", "potential" or similar expressions or by a general discussion of the Company's strategies, plans or intentions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results of operations, financial position, earnings, achievements, or industry results, to be materially different from any future results, earnings or achievements expressed or implied by such forward-looking statements. Given these uncertainties, prospective investors and partners are cautioned not to place undue reliance on such forward-looking statements. We disclaim any obligation to update any such forward-looking statements to reflect future events or developments.

Advanced Proteome Therapeutics Corporation Dr. Randal D. Chase President and CEO Tel: 905-252-3629 Advanced Proteome Therapeutics Corporation Babak Pedram Investor Relations Virtus Advisory Group Inc. Tel: 416-644-5081 NEXT ARTICLE

More From BioPortfolio on "Advanced Proteome Therapeutics Announces 2017 AGM Results and Corporate Update"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...